What is CAVADEXTRIN®

In 2016, German scientists discovered that a compound “Cyclodextrin” reduced arterial plaque in mice. Cholrem Pty Ltd researched cyclodextrins and engineered a specific cyclodextrin with enhanced cholesterol transport capabilities. This new cyclodextrin "CAVADEXTRIN®" is a ring-shaped structure made from starch. CAVADEXTRIN® is only several atoms wide and has a cavity in the middle. The outside of the ring is attracted to water and the inside cavity is attracted to oils and lipids (like cholesterol).

When CAVADEXTRIN® circulates around the vascular system, cholesterol is sucked into the cavity and the cholesterol binds with the CAVADEXTRIN® and is transported out of the body via the urine.

Remchol for home use

CAVADEXTRIN® can only be absorbed into the blood stream when administered as an IV or as an enema.
RemChol delivers CAVADEXTRIN® via an enema.
Each tube contains 8 grams of CAVADEXTRIN® with over 2 grams absorbed into the blood stream with every treatment.

Remchol tubes can be administered as often as twice a day.

Available now

CAVADEXTRIN® cleares the vascular system and can extend lifespan.

In 2014 at the University of Texas Southwest Medical Center, a study was conducted on the effects of Cyclodextrin administered to mice. They studied the lifespan of mice treated systemically with either saline or Cyclodextrin at weekly intervals starting at 49 days of age until death. In each case, half of the males and females were given Cyclodextrin and the remaining mice received only saline.

During the study, the mice were graded on their neurological function. There were no gender related differences in the neurological scores. This score, which broadly measures neurological function, declines as the animal’s condition deteriorates.
It is clear that Cyclodextrin treated mice showed higher neurological scores than compared with the mice given saline only.

All the mice given saline only had died by 98 days whereas the majority of those receiving Cyclodextrin died in the week following. This shows an almost 10% improvement in lifespan.

The human trial of CAVADEXTRIN conducted by Cholrem has consistantly shown the scientific evidence proving the benefits of Cyclodextrin on mice also has simular benefits on humans. It would be fair to assume that based on the science, humans treated with CAVADEXTRIN would also experience a simular benefit of lifespan extention as the mice.